2-(NEOPENTYLOXYCARBONYL)-5-(TRIFLUOROMETHYL)PHENYLBORONIC ACID, 95.0%, 250mg

2-Ethoxy-6-fluoro-benzonitrile, 98.0%, 1g

(1S,5S)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-1-carboxylic acid, 98%, 1g

4-Chloro-2-(pyridin-2-yl)pyrimidine, 95.0%, 5g

Trial kit Spectra/Por® Biotech CE, 1000000 dalton(s), 1 Piece(s)

(3-Butoxy-5-methoxyphenyl)boronic acid, 95.0%, 100mg

2-AMINO-N-CYCLOPROPYLACETAMIDE HCL, 95.0%, 2.5g

1-(Chloromethyl)-4-nitro-1H-pyrazole, 5g

1H-Indazol-5-amine, 97.0%, 10g

4-Aminobenzene-1,3-diol hydrochloride, 96.0%, 5g

1-[2-(Dimethylamino)ethyl]-1H-pyrazole-4-carboxylic acid, 95%, 50mg

4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile, 97.0%, 10g

1-Methyl-3-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]-2-pyridyl]amino]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-one, 97%, 250mg